J.Molner AS (OTSE:MOLNR) Change In Receivables : €0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Change In Receivables?

J.Molner AS's change in receivables for the quarter that ended in Dec. 2023 was €0.00 Mil. It means J.Molner AS's Accounts Receivable stayed the same from Jun. 2023 to Dec. 2023 .

J.Molner AS's change in receivables for the fiscal year that ended in Dec. 2023 was €0.00 Mil. It means J.Molner AS's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

J.Molner AS's Accounts Receivable for the quarter that ended in Dec. 2023 was €0.07 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. J.Molner AS's Days Sales Outstanding for the six months ended in Dec. 2023 was 36.82.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. J.Molner AS's liquidation value for the six months ended in Dec. 2023 was €-2.69 Mil.

J.Molner AS Change In Receivables Historical Data

The historical data trend for J.Molner AS's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Change In Receivables Chart

J.Molner AS Annual Data

Trend

Dec21

Dec22

Dec23

Change In Receivables

J.Molner AS Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	-	-	-	-	-

J.Molner AS Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

J.Molner AS (OTSE:MOLNR) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

J.Molner AS's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.07	/	0.347	*	91
=	36.82

2. In Ben Graham's calculation of liquidation value, J.Molner AS's accounts receivable are only considered to be worth 75% of book value:

J.Molner AS's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.093	-	2.867	+	0.75 * 0.07	+	0.5 * 0.072
=	-2.69

J.Molner AS Change In Receivables Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

J.Molner AS (OTSE:MOLNR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618

Website

https://www.jmolner.com

J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines